Inventor · disambiguated record
Raymond Andersen
Also filed as: ANDERSEN RAYMOND · ANDERSEN RAYMOND C · ANDERSEN RAYMOND J · ANDERSEN RAYMOND JOHN
42 granted patents·32 pending applications·413 citations·filing 1991–2024
98Inventor score
Files withUNIV BRITISH COLUMBIA35ESSA PHARMA INC5BRITISH COLUMBIA CANCER AGENCY BRANCH4SADAR MARIANNE D4BRITISH COLUMBIA CANCER AGENCY3
Top patents by PatentIndex Score
74 records- 0197US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0295US11345670B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2020·Granted May 31, 2022·5 cites·31 claims
- 0394US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 0494US11142508B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 12, 2021·4 cites·24 claims
- 0594US10654811B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2016·Granted May 19, 2020·11 cites·37 claims
- 0694US9365510B2Aziridine bisphenol ethers and related compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Jun 14, 2016·16 cites·46 claims
- 0793US8686050B2Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Apr 1, 2014·19 cites·14 claims
- 0893US7410951B2Biologically active peptides and compositions, their useUNIV BRITISH COLUMBIA·Filed 2005·Granted Aug 12, 2008·16 cites·11 claims
- 0992US9173939B2Ester derivatives of androgen receptor modulators and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Nov 3, 2015·20 cites·29 claims
- 1092US7772397B2Biologically active peptides and compositions, their useUNIV BRITISH COLUMBIA·Filed 2008·Granted Aug 10, 2010·16 cites·13 claims
- 1191US9000050B2SHIP1 modulators and related methodsWANG XIAOXIA·Filed 2011·Granted Apr 7, 2015·13 cites·16 claims
- 1289US9862667B2Diglycidic ether derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2009·Granted Jan 9, 2018·14 cites·45 claims
- 1387US9388112B2Bisphenol derivatives and their use as androgen receptor activity modulatorsSADAR MARIANNE D·Filed 2011·Granted Jul 12, 2016·15 cites·34 claims
- 1487US9375496B2Halogenated compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Jun 28, 2016·16 cites·23 claims
- 1587US6870028B1Biologically active peptides and compositions, their useUNIV BRITISH COLUMBIA·Filed 2000·Granted Mar 22, 2005·16 cites·13 claims
- 1687US6153590ABiologically active peptides and compositions, their useUNIV ALBERTA·Filed 1996·Granted Nov 28, 2000·72 cites·12 claims
- 1786US10471023B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2016·Granted Nov 12, 2019·5 cites·28 claims
- 1885US2025100986A1Bisphenol derivatives and their use as androgen receptor activity modulatorsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 1984US6784283B2Peptide antibioticsUNIV BRITISH COLUMBIA·Filed 2001·Granted Aug 31, 2004·27 cites·25 claims
- 2084US2024391883A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 2183US8765994B2Ship 1 modulatorsANDERSEN RAYMOND·Filed 2011·Granted Jul 1, 2014·6 cites·24 claims
- 2277US7799776B2Indoleamine 2,3-dioxygenase (IDO) inhibitorsUNIV BRITISH COLUMBIA·Filed 2005·Granted Sep 21, 2010·11 cites·12 claims
- 2375US11919874B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 2475US9682933B2Androgen receptor modulators and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2015·Granted Jun 20, 2017·2 cites·30 claims
- 2575US9487479B2Small molecule inhibitors of N-terminus activation of the androgen receptorSADAR MARIANNE D·Filed 2009·Granted Nov 8, 2016·2 cites·54 claims
- 2675US2022267283A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 2774US12011421B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2021·Granted Jun 18, 2024·0 cites·5 claims
- 2874US7579323B1Hemiasterlin analogsUNIV BRITISH COLUMBIA·Filed 1998·Granted Aug 25, 2009·28 cites·49 claims
- 2970US8956824B2Methods for identifying allosteric modulators of ship polypeptidesMUI ALICE·Filed 2009·Granted Feb 17, 2015·1 cites·37 claims
- 3069US11197832B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2020·Granted Dec 14, 2021·0 cites·5 claims
- 3169US8148336B2Sterol glucoside toxinsSHAW CHRISTOPHER ARIEL·Filed 2006·Granted Apr 3, 2012·3 cites·16 claims
- 3269US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 3367US11779550B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 10, 2023·0 cites·10 claims
- 3467US8497123B2Sterol glucoside toxinsSHAW CHRISTOHPER A·Filed 2012·Granted Jul 30, 2013·2 cites·5 claims
- 3565US7067494B2Antimitotic eleuthesidesUNIV BRITISH COLUMBIA·Filed 2002·Granted Jun 27, 2006·3 cites·17 claims
- 3665US6291447B1Granulatimide compounds and uses thereofUNIV BRITISH COLUMBIA·Filed 1999·Granted Sep 18, 2001·23 cites·22 claims
- 3764US10751296B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2017·Granted Aug 25, 2020·0 cites·12 claims
- 3864US8431541B2Alpha-amylase inhibitors: the montbretins and uses thereofWITHERS STEPHEN·Filed 2008·Granted Apr 30, 2013·1 cites·25 claims
- 3959US2009264487A1Hemiasterlin analogsUNIV BRITISH COLUMBIA·Filed 2009·Application pending·0 cites
- 4059US2020206155A1Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2019·Application pending·0 cites
- 4158US12109179B2Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Granted Oct 8, 2024·0 cites·23 claims
- 4258US5506221AContignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agentsUNIV BRITISH COLUMBIA·Filed 1994·Granted Apr 9, 1996·20 cites·11 claims
- 4357US2025195464A1Alotaketal compounds and derivatives thereof for use as antiviral agentsUNIV BRITISH COLUMBIA·Filed 2023·Application pending·0 cites
- 4457US2018235925A1Bisphenol compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Application pending·0 cites
- 4557US2008090909A1Ship 1 ModulatorsUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
- 4656US2017298033A1Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2017·Application pending·0 cites
- 4754US2005222126A1Antiangiogenic compounds and an assay for inhibitors of cell invasionROSKELLEY CALVIN·Filed 2005·Application pending·0 cites
- 4853US2014248263A1Bisphenol compounds and methods for their useANDERSEN RAYMOND JOHN·Filed 2012·Application pending·0 cites
- 4953US2023167115A1Antiviral Agents, Uses Thereof and Methods for Their PreparationUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 5052US2011263539A1Ship 1 modulator compoundsUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Raymond Andersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →